FWL Investment Management’s iShares 1-5 Year Investment Grade Corporate Bond ETF IGSB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.9K Buy
265
+5
+2% +$262 ﹤0.01% 286
2026
Q1
$13.7K Buy
260
+30
+13% +$1.59K ﹤0.01% 241
2025
Q4
$12.2K Hold
230
– – ﹤0.01% 261
2025
Q3
$12.2K Hold
230
– – ﹤0.01% 235
2025
Q2
$12.1K Hold
230
– – ﹤0.01% 218
2025
Q1
$12K Buy
230
+30
+15% +$1.56K ﹤0.01% 216
2024
Q4
$10.3K Hold
200
– – ﹤0.01% 242
2024
Q3
$10.5K Hold
200
– – ﹤0.01% 235
2024
Q2
$10.2K Hold
200
– – 0.01% 192
2024
Q1
$10.3K Hold
200
– – 0.01% 165
2023
Q4
$10.3K Hold
200
– – 0.01% 159
2023
Q3
$9.97K Buy
+200
New +$10K 0.01% 148
2023
Q1
– Sell
-250
Closed -$12.5K – 131
2022
Q4
$12.5K Buy
+250
New +$12.4K 0.01% 134

Other funds holding IGSB

FWL Investment Management's IGSB Position: Q2 2026 in Review

FWL Investment Management increased its iShares 1-5 Year Investment Grade Corporate Bond ETF (IGSB) stake by 1.9% in Q2 2026, buying an estimated $262 and bringing the position to 265 shares worth $13.9K. The position accounts for ﹤0.01% of the portfolio, ranked #286.

FWL Investment Management first reported a position in IGSB in Q4 2022 and has held it in 13 quarters since. 1,010 funds tracked by Wall St. Rank hold IGSB as of Q2 2026.

  • FWL Investment Management held 265 shares of iShares 1-5 Year Investment Grade Corporate Bond ETF worth $13.9K as of Q2 2026.
  • FWL Investment Management bought 5 iShares 1-5 Year Investment Grade Corporate Bond ETF shares in Q2 2026, an estimated $262.
  • iShares 1-5 Year Investment Grade Corporate Bond ETF made up ﹤0.01% of FWL Investment Management's portfolio in Q2 2026, its #286 holding.
  • FWL Investment Management first reported a position in iShares 1-5 Year Investment Grade Corporate Bond ETF in Q4 2022 and has held it in 13 quarters since.
  • 1,010 funds tracked by Wall St. Rank held iShares 1-5 Year Investment Grade Corporate Bond ETF as of Q2 2026.

Based on FWL Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.